Table 4.

Parameters for Cox proportional-hazard regression models for overall survival in patients with ovarian cancer, (regression coefficients, standard errors, p values, Hazard Ratios, and 95% confidence intervals for Hazard Ratios).

	B	S.E.	P- Value	Hazard Ratio	95% CI
Stage (early vs advanced)	−0.338	0.241	0.161	0.713	0.445–1.143
Grade (low vs high)	−0.192	0.378	0.612	0.825	0.393–1.732
Cytoreduction , (optimal vs suboptimal)	0.105	0.157	0.506	1.110	0.816–1.512
Age	0.026	0.014	0.055	1.027	0.999–1.055
Nocturnal Cortisola	0.375	0.162	0.021	1.455	1.059–1.998
	B	S.E.	P- Value	Hazard Ratio	95% CI
Stage (early vs advanced	−0.341	0.241	0.158	0.711	0.443–1.141
Grade (low vs high)	−0.241	0.381	0.527	0.786	0.373–1.657
Cytoreduction , (optimal vs suboptimal)	0.119	0.157	0.451	1.126	0.827–1.533
Age	0.030	0.013	0.022	1.031	1.004–1.058
Cortisol Slopeb	0.325	0.158	0.040	1.384	1.015–1.886
	B	S.E.	P- Value	Hazard Ratio	95% CI
Stage (early vs advanced)	−0.350	0.238	0.140	0.704	0.442–1.122
Grade (low vs high)	−0.260	0.377	0.491	0.771	0.368–1.615
Cytoreduction, (optimal vs suboptimal)	0.110	0.158	0.485	1.116	0.820–1.520
Age	0.030	0.014	0.025	1.031	1.004–1.059
Cortisol Variabilityc	−0.314	0.127	0.013	0.731	0.570–0.937

^aGreater hazard reflects 1 SD increase night cortisol (.787 nmol/L, (ln))

^bGreater hazard reflects 1 SD smaller hourly decline in salivary cortisol (.049 nmol/L, (ln)).

^cSmaller hazard reflects 1 SD greater decline in salivary cortisol over course of the day (21.4%)